Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis

ClinicalTrials.gov ID: NCT02315898

Public ClinicalTrials.gov record NCT02315898. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 3:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Efficacy of Inhaled Tissue Plasminogen Activator (tPA) for the Acute Treatment of Pediatric Plastic Bronchitis

Study identification

NCT ID
NCT02315898
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
University of Michigan
Other
Enrollment
40 participants

Conditions and interventions

Interventions

  • Treatment-inhaled tPA Drug

Drug

Eligibility (public fields only)

Age range
5 Years to 24 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 18, 2018
Primary completion
Mar 4, 2021
Completion
Jun 29, 2023
Last update posted
Aug 18, 2025

2018 – 2023

United States locations

U.S. sites
6
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
Lucile Packard Children's Hospital, Stanford University Palo Alto California 94304
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611
University of Michigan Mott Children's Hospital Ann Arbor Michigan 48109
Cincinnati Children's Hospital Cincinnati Ohio 45229
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Medical University of South Caroline Charleston South Carolina 29425

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02315898, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 18, 2025 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02315898 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →